Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Eman Mohamed Othman"'
Autor:
Ahmed M. Abdelrauf, Amal Mohamed Abd El Baky, Ahmed Salah El-Khodary, Hamed M Kadry, Eman Mohamed Othman
Publikováno v:
Fizjoterapia Polska. 22:60-64
Background. Secondary lymphedema results from a known insult to the lymphatic system. Worldwide, secondary lymphedema is more common than primary lymphedema. Compression therapy is the mainstay of management for all stages of lymphedema. Purpose. To
Autor:
Eman Mohamed Othman, Yasmeen Hamada Lotfy Mohamed, Ahmed Mohamed Kenawy, Rokaia Ali Zain El-Abedeen Toson
Publikováno v:
Fizjoterapia Polska. 21:116-121
Background. Hypertrophic scar (HTS) formation after burn remains a major issue for burned patients and is considered a huge problem for clinicians because the hypertrophic scar is painful, reddish, elevated, pruritic, and aesthetically unacceptable.
Autor:
Eman Mohamed Othman, Doaa A Aly
Publikováno v:
Journal of burn careresearch : official publication of the American Burn Association.
This is an observational cross-sectional study design aimed to assess the feasibility and reliability of the Arabic version of WeeFIM in Egyptian children with healed burns with two measurements within a 2-week time period in a sample of 53 patients
Autor:
Eman Mohamed Othman Mosaad, Hassendrini N. Peiris, Natalie Turner, Murray D. Mitchell, Isabella Morean Garcia, Pevindu Abeysinghe
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 9106, p 9106 (2020)
International Journal of Molecular Sciences, Vol 21, Iss 9106, p 9106 (2020)
Abnormal uterine function affects conception rate and embryo development, thereby leading to poor fertility and reproduction failure. Exosomes are a nanosized subclass of extracellular vesicles (EV) that have important functions as intercellular comm
Autor:
Karen F. Chambers, Judith A. Clements, Katarzyna Futrega, Michael R. Doran, Eman Mohamed Othman Mosaad
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
Scientific Reports
Scientific Reports
Treatment following early diagnosis of Prostate cancer (PCa) is increasingly successful, whilst the treatment of advanced and metastatic PCa remains challenging. A major limitation in the development of new therapies is the prediction of drug efficac
Autor:
Karen F. Chambers, Michael R. Doran, Brian S. Gloss, Katarzyna Futrega, Judith A. Clements, Inge Seim, Eman Mohamed Othman Mosaad
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports
Scientific Reports
It is routine to genetically modify cells to express fluorescent or bioluminescent reporter proteins to enable tracking or quantification of cells in vitro and in vivo. Herein, we characterized the stability of luciferase reporter systems in C4-2B pr
Autor:
Eman Mohamed Othman Mosaad, Judith A. Clements, Karen F. Chambers, Katarzyna Futrega, Michael R. Doran
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Background There is increasing appreciation that non-cancer cells within the tumour microenvironment influence cancer progression and anti-cancer drug efficacy. For metastatic prostate cancer (PCa), the bone marrow microenvironment influences metasta
Autor:
Michael R. Doran, Kathryn Futrega, Karen F. Chambers, Judith A. Clements, Eman Mohamed Othman Mosaad, William B. Lott
Publikováno v:
Cell and Tissue Research
Bone marrow-derived mesenchymal stem/stromal cells (BMSC) may facilitate bone repair through secretion of factors that stimulate endogenous repair processes or through direct contribution to new bone through differentiation into osteoblast-like cells
Publikováno v:
Experimental Hematology. 43:S60
Autor:
Judith A. Clements, Karen F. Chambers, Michael R. Doran, Pamela J. Russell, Eman Mohamed Othman Mosaad
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 11, p e111029 (2014)
PLoS ONE, Vol 9, Iss 11, p e111029 (2014)
Despite monolayer cultures being widely used for cancer drug development and testing, 2D cultures tend to be hypersensitive to chemotherapy and are relatively poor predictors of whether a drug will provide clinical benefit. Whilst generally more comp